e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
COPD: chronic disease and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictors of coronary heart disease in patients with COPD
Anastasiia Savytska (Vinnitsa, Ukraine), Anastasiia Savytska
Source:
International Congress 2015 – COPD: chronic disease and comorbidities
Session:
COPD: chronic disease and comorbidities
Session type:
Thematic Poster Session
Number:
689
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anastasiia Savytska (Vinnitsa, Ukraine), Anastasiia Savytska. Predictors of coronary heart disease in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 689
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Effectiveness of vaccination of patients with combination of COPD and coronary heart disease (CHD)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Resting heart rate and exacerbations in COPD patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Lipid profile in COPD patients with coronary artery disease comorbidity
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure
Source: International Congress 2014 – Markers
Year: 2014
The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF)
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Cardiovascular events (CVE) in COPD patients
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept